Get started
Work

Safety of Allogeneic HCT in Beta Thalassemia Patients with Chronic Hepatitis C Virus Infections Treated at a Pediatric Center

Year: 2018
Type: article
Abstract: Background: The outcome of allogeneic hematopoietic cell transplantation (HCT) in patients previously infected with hepatitis C virus (HCV) is a widely debated topic and rarely reported in the pediatric age group given the small population of affected patients. New medications targeting HCV have induced virologic cures for many patients. Their use in the pre-transplant setting may improve outcomes for patients infected with HCV.
DOI: 10.1016/j.bbmt.2017.12.479
Authors: Archana Ramgopal, Rabi Hanna, Aron Flagg, Ilia Buhtoiarov, Navneet S. Majhail, Robert M. Dean, Betty K. Hamilton, Aaron T. Gerds, Laurie Money, Kathy Bielek
Institution: Cleveland Clinic
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2791291878
FWCI:
Cites:
Cited by:
Related to: 10